Cargando…

Targeting the tumor-stromal-immune cell axis

Detalles Bibliográficos
Autores principales:	Gururajan, Murali, Josson, Sajni, Chung, Leland W.K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606004/ https://www.ncbi.nlm.nih.gov/pubmed/26501076

Ejemplares similares

Tumor-Stromal Interactions Influence Radiation Sensitivity in Epithelial- versus Mesenchymal-Like Prostate Cancer Cells
por: Josson, Sajni, et al.
Publicado: (2010)

Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics
por: Chu, Gina Chia-Yi, et al.
Publicado: (2019)

Inhibition of β2-Microglobulin/Hemochromatosis Enhances Radiation Sensitivity by Induction of Iron Overload in Prostate Cancer Cells
por: Josson, Sajni, et al.
Publicado: (2013)

Future perspectives of prostate cancer therapy
por: Gururajan, Murali, et al.
Publicado: (2012)

SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer
por: Gururajan, Murali, et al.
Publicado: (2015)

Applications of circulating tumor cells for prostate cancer
por: Cheng, Shirley, et al.
Publicado: (2016)

In Vivo Targeting of ADAM9 Gene Expression Using Lentivirus-Delivered shRNA Suppresses Prostate Cancer Growth by Regulating REG4 Dependent Cell Cycle Progression
por: Liu, Che-Ming, et al.
Publicado: (2013)

β2-Microglobulin-mediated Signaling as a Target for Cancer Therapy
por: Nomura, Takeo, et al.
Publicado: (2014)

Biology and therapy of urological cancer metastasis
por: Posadas, Edwin M., et al.
Publicado: (2016)

Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer
por: Wu, Jason, et al.
Publicado: (2013)

MicroRNA-185 and 342 Inhibit Tumorigenicity and Induce Apoptosis through Blockade of the SREBP Metabolic Pathway in Prostate Cancer Cells
por: Li, Xiangyan, et al.
Publicado: (2013)

miR-17* Suppresses Tumorigenicity of Prostate Cancer by Inhibiting Mitochondrial Antioxidant Enzymes
por: Xu, Yong, et al.
Publicado: (2010)

Cultured circulating tumor cells and their derived xenografts for personalized oncology
por: Wang, Ruoxiang, et al.
Publicado: (2016)

(R)-2-hydroxyglutarate drives immune quiescence in the tumor microenvironment of IDH-mutant gliomas
por: Richardson, Leland G., et al.
Publicado: (2019)

Toll-Like Receptor Expression and Responsiveness of Distinct Murine Splenic and Mucosal B-Cell Subsets
por: Gururajan, Murali, et al.
Publicado: (2007)

Mesenchymal stromal cells as regulators of anti-tumour immune response
por: Poggi, Alessandro, et al.
Publicado: (2015)

Induction of integrin α(2) in a highly bone metastatic human prostate cancer cell line: roles of RANKL and AR under three-dimensional suspension culture
por: Ziaee, Shabnam, et al.
Publicado: (2014)

Mesenchymal Stromal Cells: From Therapeutic Option to Therapeutic Target
por: Stefani, Francesca Romana, et al.
Publicado: (2023)

EPLIN Downregulation Promotes Epithelial-Mesenchymal Transition in Prostate Cancer Cells and Correlates With Clinical Lymph Node Metastasis
por: Zhang, Shumin, et al.
Publicado: (2011)

Current research and treatment for gastrointestinal stromal tumors
por: Lim, Kheng Tian, et al.
Publicado: (2017)

MicroRNAs as regulators of tumor-associated stromal cells
por: Ell, Brian, et al.
Publicado: (2013)

Role of Stromal Cells in Determining Tumor and Cancer Stem Cell Behaviors and Therapeutic Response
por: Reshkin, Stephan J., et al.
Publicado: (2020)

Improving the Therapeutic Ability of Mesenchymal Stem/Stromal Cells for the Treatment of Conditions Influenced by Immune Cells
por: da Silva Meirelles, Lindolfo, et al.
Publicado: (2019)

Overcoming heterogenity in imatinib-resistant gastrointestinal stromal tumor
por: Serrano, César, et al.
Publicado: (2019)

Recent advances in the systemic treatment of gastrointestinal stromal tumors
por: Jones, Robin L., et al.
Publicado: (2023)

Mesenchymal Stem/Stromal Cells in Immunity and Disease: A Better Understanding for an Improved Use
por: Merimi, Makram, et al.
Publicado: (2020)

Metastasis suppression and enhancement of anti-tumour immunity by targeting the FSTL1-DIP2A axis
por: Sundaram, Gopinath M., et al.
Publicado: (2019)

Introducing the Asian Journal of Urology
por: Sun, Yinghao, et al.
Publicado: (2014)

COVID-19 infection in cancer patients: early observations and unanswered questions
por: Oh, W.K.
Publicado: (2020)

Immune Infiltration, Cancer Stemness, and Targeted Therapy in Gastrointestinal Stromal Tumor
por: Wang, Jingjing, et al.
Publicado: (2021)

Modulation of cabozantinib efficacy by the prostate tumor microenvironment
por: Tripathi, Manisha, et al.
Publicado: (2017)

Targeting on the NAD(+)‐mitophagy axis to treat cardiovascular disease
por: Fang, Evandro F., et al.
Publicado: (2020)

Adipose-Derived Stromal/Stem Cells
por: Baer, Patrick C.
Publicado: (2020)

Molecular Morphology and Function of Stromal Cells
por: Manetti, Mirko
Publicado: (2021)

Mesenchymal Stromal Cell-Based Therapy
por: Mönch, Dina, et al.
Publicado: (2023)

Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment
por: Pan, Xingyi, et al.
Publicado: (2020)

The Anti-inflammatory Role of Endometase/Matrilysin-2 in Human Prostate Cancer Cells
por: Khamis, Zahraa I., et al.
Publicado: (2013)

Targeting Innate Immune Cells for Immunotherapy
por: Carreño, Leandro J., et al.
Publicado: (2017)

The IL-33/IL-31 Axis in Allergic and Immune-Mediated Diseases
por: Murdaca, Giuseppe, et al.
Publicado: (2023)

Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations
por: Li, Xiangyan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ih3hjed8otm5mcojtkhnjnmgtt